In this scheme, both CaMKII and late INa were activated by β-adrenergic stimulation, and augmented late INa was also mediated by activation of CaMKII, providing a mechanism for the combined effect of inhibitors of CaMKII and late INa on AF prevention. Here, CAMK2G is linked to atrial fibrillation.